I'll I'll I still prescribe it to patients all the time if they're insulin resistant for sure it's still a valuable drug but I don't think of it as a great tool for the person who's insulin sensitive and exercising a lot
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
I'll I'll I still prescribe it to patients all the time if they're insulin resistant for sure it's still a valuable drug but I don't think of it as a great tool for the person who's insulin sensitive and exercising a lot
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
don't think it's really disputable how big those benefits are in people who have diabetes I think that is becoming very clear and then by extension in people who are insulin resistant
I'll I still prescribe it to patients all the time if they're insulin resistant for sure it's still a valuable drug but I don't think of it as a great tool for the person who's insulin sensitive and exercising a lot